|
Re: SP 52 week low
|
5
|
Resverlogix Corp.
|
Oct 06, 2022 01:08PM
|
|
Re: Thoughts on ZCC
|
5
|
Zenith Epigenetics
|
Sep 13, 2021 05:34PM
|
|
Re: Will we see a Zenith deal before years end???
|
5
|
Zenith Epigenetics
|
Nov 16, 2018 11:25AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
5
|
Zenith Epigenetics
|
Jan 30, 2019 12:14PM
|
|
Re: ASCO 2019 coming up May 31 to June 4
|
5
|
Zenith Epigenetics
|
May 27, 2019 12:25PM
|
|
Re: Trump and his Parma meeting today.
|
5
|
Resverlogix Corp.
|
Jan 31, 2017 02:50PM
|
|
Re: Question for the board!
|
5
|
Zenith Epigenetics
|
Jan 22, 2019 01:39PM
|
|
Re: What are we waiting on?
|
5
|
Resverlogix Corp.
|
Dec 01, 2021 12:50PM
|
|
Re: keep doing PPs at .48/shr with a .50 warrant good till 2025 donny
|
5
|
Resverlogix Corp.
|
May 05, 2022 04:36PM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 06:04PM
|
|
Re: Shrinking MACE event rate
|
5
|
Resverlogix Corp.
|
Jan 19, 2019 04:11PM
|
|
Re: Name Confusion
|
5
|
Zenith Epigenetics
|
Jul 29, 2020 11:57AM
|
|
Re: New Variant
|
6
|
Resverlogix Corp.
|
Nov 27, 2021 11:48AM
|
|
Re: Trading
|
6
|
Zenith Epigenetics
|
Sep 22, 2022 03:27PM
|
|
Re: New Variant
|
6
|
Resverlogix Corp.
|
Nov 27, 2021 03:36PM
|
|
Re: Critique rvx-208 Science
|
6
|
Resverlogix Corp.
|
Nov 25, 2015 12:13PM
|
|
Re: best case, worse case???
|
6
|
Resverlogix Corp.
|
Oct 07, 2021 07:15PM
|
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
6
|
Zenith Epigenetics
|
Nov 20, 2018 11:34AM
|
|
Re: The latest numbers for Alberta.
|
6
|
Resverlogix Corp.
|
Sep 17, 2021 07:06AM
|
|
Re: Don On 630 CHED's Afternoon Show
|
6
|
Resverlogix Corp.
|
Jan 20, 2022 05:46PM
|
